US Stem Cell Inc (USRM)

[NoMoDo]

I think it isn't climbing yet because the company nearly went bankrupt trying to get FDA approval over the years and few people know how the business has changed virtually overnight.

They needed a finance guy instead of a just group of really smart science people. About a month ago, they got got a finance guy added to their board. He cleaned up the balance sheet and the income statement too. He created a viable plan to grow the income exponentially with or without FDA approval. Keep in mind that they need FDA approval for repairing the heart and a few other procedures they want to perform, but they currently have a whole line of stem cell services that do not require FDA approval that is already producing revenue.

Not getting FDA approval would bring the stock down to about half it's current value, but will still likely be over a buck in one or two quarters. I am not sure how much of the change will be reported in the next Q, but the quarter ending June 30 should be exceptional. Likely showing a net profit.